Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 610

1.

Humoral immunodeficiencies: conferred risk of infections and benefits of immunoglobulin replacement therapy.

Gernez Y, Baker MG, Maglione PJ.

Transfusion. 2018 Dec;58 Suppl 3:3056-3064. doi: 10.1111/trf.15020.

PMID:
30536429
2.

A tetrameric form of CD40 ligand with potent biological activities in both mouse and human primary B cells.

Lai N, Min Q, Xiong E, Liu J, Zhang L, Yasuda S, Wang JY.

Mol Immunol. 2018 Dec 6;105:173-180. doi: 10.1016/j.molimm.2018.11.018. [Epub ahead of print]

PMID:
30529036
3.

Disseminated cryptococcosis in two boys with novel mutation of CD40 Ligand-Associated X-linked hyper-IgM syndrome.

Pacharn P, Phongsamart W, Boonyawat B, Jirapongsananuruk O, Visitsunthorn N, Chokephaibulkit K.

Asian Pac J Allergy Immunol. 2018 Oct 15. doi: 10.12932/AP-190618-0341. [Epub ahead of print]

4.

The hyper IgM syndromes: Epidemiology, pathogenesis, clinical manifestations, diagnosis and management.

Yazdani R, Fekrvand S, Shahkarami S, Azizi G, Moazzami B, Abolhassani H, Aghamohammadi A.

Clin Immunol. 2018 Nov 13;198:19-30. doi: 10.1016/j.clim.2018.11.007. [Epub ahead of print] Review.

PMID:
30439505
5.

Infectious etiology of chronic diarrhea in patients with primary immunodeficiency diseases.

Parvaneh L, Sharifi N, Azizi G, Abolhassani H, Sharifi L, Mohebbi A, Bahraminia E, Delavari S, Alebouyeh M, Tajeddin E, Mohebbi SR, Yazdani R, Behniafard N, Aghamohammadi A.

Eur Ann Allergy Clin Immunol. 2018 Nov 12. doi: 10.23822/EurAnnACI.1764-1489.77. [Epub ahead of print]

PMID:
30417635
6.

An X-Linked Hyper-IgM Patient Followed Successfully for 23 Years without Hematopoietic Stem Cell Transplantation.

Kutukculer N, Karaca NE, Aksu G, Aykut A, Pariltay E, Cogulu O.

Case Reports Immunol. 2018 Oct 14;2018:6897935. doi: 10.1155/2018/6897935. eCollection 2018.

7.

Posttransplant recipient-derived CD4+ T-cell lymphoproliferative disease in X-linked hyper-IgM syndrome.

Hagio Y, Shiraishi A, Ishimura M, Sonoda M, Eguchi K, Yamamoto H, Oda Y, Ohga S.

Pediatr Blood Cancer. 2018 Oct 30:e27529. doi: 10.1002/pbc.27529. [Epub ahead of print] No abstract available.

PMID:
30378267
8.

Primary B-cell immunodeficiencies.

Smith T, Cunningham-Rundles C.

Hum Immunol. 2018 Oct 22. pii: S0198-8859(18)30254-4. doi: 10.1016/j.humimm.2018.10.015. [Epub ahead of print] Review.

PMID:
30359632
9.

Advances in site-specific gene editing for primary immune deficiencies.

Kuo CY.

Curr Opin Allergy Clin Immunol. 2018 Dec;18(6):453-458. doi: 10.1097/ACI.0000000000000483.

PMID:
30299399
10.

Comparison of Common Monogenic Defects in a Large Predominantly Antibody Deficiency Cohort.

Yazdani R, Abolhassani H, Kiaee F, Habibi S, Azizi G, Tavakol M, Chavoshzadeh Z, Mahdaviani SA, Momen T, Gharagozlou M, Movahedi M, Hamidieh AA, Behniafard N, Nabavi M, Bemanian MH, Arshi S, Molatefi R, Sherkat R, Shirkani A, Amin R, Aleyasin S, Faridhosseini R, Jabbari-Azad F, Mohammadzadeh I, Ghaffari J, Shafiei A, Kalantari A, Mansouri M, Mesdaghi M, Babaie D, Ahanchian H, Khoshkhui M, Soheili H, Eslamian MH, Cheraghi T, Dabbaghzadeh A, Tavassoli M, Kalmarzi RN, Mortazavi SH, Kashef S, Esmaeilzadeh H, Tafaroji J, Khalili A, Zandieh F, Sadeghi-Shabestari M, Darougar S, Behmanesh F, Akbari H, Zandkarimi M, Abolnezhadian F, Fayezi A, Moghtaderi M, Ahmadiafshar A, Shakerian B, Sajedi V, Taghvaei B, Safari M, Heidarzadeh M, Ghalebaghi B, Fathi SM, Darabi B, Bazregari S, Bazargan N, Fallahpour M, Khayatzadeh A, Javahertrash N, Bashardoust B, Zamani M, Mohsenzadeh A, Ebrahimi S, Sharafian S, Vosughimotlagh A, Tafakoridelbari M, Rahim M, Ashournia P, Razaghian A, Rezaei A, Samavat A, Mamishi S, Khazaei HA, Mohammadi J, Negahdari B, Parvaneh N, Rezaei N, Lougaris V, Giliani S, Plebani A, Ochs HD, Hammarström L, Aghamohammadi A.

J Allergy Clin Immunol Pract. 2018 Sep 19. pii: S2213-2198(18)30579-8. doi: 10.1016/j.jaip.2018.09.004. [Epub ahead of print]

PMID:
30240888
11.

The RNA-binding protein ROD1/PTBP3 cotranscriptionally defines AID-loading sites to mediate antibody class switch in mammalian genomes.

Chen J, Cai Z, Bai M, Yu X, Zhang C, Cao C, Hu X, Wang L, Su R, Wang D, Wang L, Yao Y, Ye R, Hou B, Yu Y, Yu S, Li J, Xue Y.

Cell Res. 2018 Oct;28(10):981-995. doi: 10.1038/s41422-018-0076-9. Epub 2018 Aug 24.

12.

Circulating Follicular Helper and Follicular Regulatory T Cells Are Severely Compromised in Human CD40 Deficiency: A Case Report.

Cicalese MP, Gerosa J, Baronio M, Montin D, Licciardi F, Soresina A, Dellepiane RM, Miano M, Baselli LA, Volpi S, Dufour C, Plebani A, Aiuti A, Lougaris V, Fousteri G.

Front Immunol. 2018 Aug 6;9:1761. doi: 10.3389/fimmu.2018.01761. eCollection 2018.

13.

Genetic Analysis of Patients with Two Different Types of Hyper IgM Syndrome.

Alizadeh Z, Mazinani M, Houshmand M, Shakerian L, Nourizadeh M, Pourpak Z, Fazlollahi MR.

Immunol Invest. 2018 Oct;47(7):745-753. doi: 10.1080/08820139.2018.1493052. Epub 2018 Aug 6.

PMID:
30081731
14.

Clinical and molecular features of X-linked hyper IgM syndrome - An experience from North India.

Rawat A, Mathew B, Pandiarajan V, Jindal A, Sharma M, Suri D, Gupta A, Goel S, Karim A, Saikia B, Minz RW, Imai K, Nonoyama S, Ohara O, Giliani SC, Notarangelo LD, Chan KW, Lau YL, Singh S.

Clin Immunol. 2018 Oct;195:59-66. doi: 10.1016/j.clim.2018.07.013. Epub 2018 Jul 25.

PMID:
30053428
15.

No Overt Clinical Immunodeficiency Despite Immune Biological Abnormalities in Patients With Constitutional Mismatch Repair Deficiency.

Tesch VK, IJspeert H, Raicht A, Rueda D, Dominguez-Pinilla N, Allende LM, Colas C, Rosenbaum T, Ilencikova D, Baris HN, Nathrath MHM, Suerink M, Januszkiewicz-Lewandowska D, Ragab I, Azizi AA, Wenzel SS, Zschocke J, Schwinger W, Kloor M, Blattmann C, Brugieres L, van der Burg M, Wimmer K, Seidel MG.

Front Immunol. 2018 Jul 2;9:1506. doi: 10.3389/fimmu.2018.01506. eCollection 2018.

16.

Low Rates of Poliovirus Antibodies in Primary Immunodeficiency Patients on Regular Intravenous Immunoglobulin Treatment.

Costa-Carvalho BT, Sullivan KE, Fontes PM, Aimé-Nobre F, Gonzales IGS, Lima ES, Granato C, de Moraes-Pinto MI.

J Clin Immunol. 2018 Jul 14. doi: 10.1007/s10875-018-0531-x. [Epub ahead of print]

PMID:
30006913
17.

Newborn screening using TREC/KREC assay for severe T and B cell lymphopenia in Iran.

Nourizadeh M, Shakerian L, Borte S, Fazlollahi M, Badalzadeh M, Houshmand M, Alizadeh Z, Dalili H, Rashidi-Nezhad A, Kazemnejad A, Moin M, Hammarström L, Pourpak Z.

Scand J Immunol. 2018 Jun 26:e12699. doi: 10.1111/sji.12699. [Epub ahead of print]

PMID:
29943473
18.

Haematopoietic stem cell transplant for hyper-IgM syndrome due to CD40 defects: a single-centre experience.

Al-Saud B, Al-Jomaie M, Al-Ghonaium A, Al-Ahmari A, Al-Mousa H, Al-Muhsen S, Al-Seraihy A, Arnaout R, Elshorbagi S, Al-Dhekri H, Ayas M.

Bone Marrow Transplant. 2018 Jun 8. doi: 10.1038/s41409-018-0219-0. [Epub ahead of print]

PMID:
29884852
19.

Site-Specific Gene Editing of Human Hematopoietic Stem Cells for X-Linked Hyper-IgM Syndrome.

Kuo CY, Long JD, Campo-Fernandez B, de Oliveira S, Cooper AR, Romero Z, Hoban MD, Joglekar AV, Lill GR, Kaufman ML, Fitz-Gibbon S, Wang X, Hollis RP, Kohn DB.

Cell Rep. 2018 May 29;23(9):2606-2616. doi: 10.1016/j.celrep.2018.04.103.

20.

A Novel de Novo Mutation in the CD40 Ligand Gene in a Patient With a Mild X-Linked Hyper-IgM Phenotype Initially Diagnosed as CVID: New Aspects of Old Diseases.

França TT, Leite LFB, Maximo TA, Lambert CG, Zurro NB, Forte WCN, Condino-Neto A.

Front Pediatr. 2018 May 4;6:130. doi: 10.3389/fped.2018.00130. eCollection 2018.

Supplemental Content

Loading ...
Support Center